Chief medical adviser at Health Canada says evidence is that the vaccine is safe and effective in the younger age group
WEDNESDAY, May 5, 2021 (HealthDay News) — The Pfizer COVID-19 vaccine has been approved by Canadian health officials for use in children ages 12 to 15 years. It was already authorized for anyone 16 years and older.
The evidence is that the vaccine is safe and effective in the younger age group, Supriya Sharma, M.D., chief medical adviser at Health Canada, said Wednesday, the Associated Press reported. The Pfizer COVID-19 vaccine is the first approved for children in Canada.
In the United States, the Food and Drug Administration is expected to authorize the Pfizer vaccine for youngsters by next week, meaning that many may be able to get shots before the start of the next school year, the AP reported.
About a month ago, Pfizer announced that its vaccine also provides protection for children ages 12 to 15 years.
.jpg)
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder 
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists 
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Youth Suicide Risk Linked to Community Firearm Violence 
Better Youth Fitness May Lower Risk for Depression in Adulthood 
Childhood Cancer Survivors Often Have Mental Distress in Adulthood 
Insomnia Linked to Increased Risk for Stroke, Odds of Admission 
Reducing Ultraprocessed Food May Alleviate Symptoms of Depression 
.jpg)